Dark

ACHV
Achieve Life Sciences, Inc.
stock NASDAQ

At Close

Jul 28, 2026 3:59:57 PM EDT

6.17USD-0.162%(-0.01)1,304,648

6.17Bid 6.18Ask 0.01Spread

Pre-market

Jul 27, 2026 9:25:30 AM EDT

6.18USD+1.311%(+0.08)0

After-hours

Jul 27, 2026 4:06:30 PM EDT

6.19USD-0.081%(-0.01)0

OverviewOptionsHistoricalExchangesShortsNews

Jan 25, 2022

11:08AM EST Achieve Life Sciences Initiates Pivotal Trial Of Cytisinicline For Smoking Cessation Benzinga

08:09AM EST Achieve Life Sciences Announces Initiation Of The Phase 3 ORCA-3 Clinical Trial Evaluating Cytisinicline For Smoking Cessation Benzinga

08:00AM EST Achieve Life Sciences Announces Initiation of the Phase 3 ORCA-3 GlobeNewswire Inc

Jan 6, 2022

08:30AM EST Achieve Life Sciences to Present at H.C. Wainwright BIOCONNECT GlobeNewswire Inc

Jan 4, 2022

08:33AM EST Achieve Life Sciences Announces Completion Of Last Subject, Last Follow-Up Visit In Phase 3 ORCA-2 Trial Of Cytisinicline For Smoking Cessation Benzinga

08:30AM EST Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced that the last study follow-up visit for the last subject enrolled in the ORCA-2 Phase 3 trial occurred in late December 2021. GlobeNewswire Inc

Dec 22, 2021

08:36AM EST Achieve Life Sciences Reports $25M Loan Facility From Silicon Valley Bank Benzinga

08:30AM EST Achieve Life Sciences Announces $25 Million Loan Facility from GlobeNewswire Inc

Nov 23, 2021

08:30AM EST Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced the Company will host a Key Opinion Leader (KOL) virtual panel event on smoking and e-cigarette cessation on Thursday, December 2nd, 2021, at 1:00 PM EST. GlobeNewswire Inc

Nov 22, 2021

08:34AM EST Achieve Life Sciences Reports Phase 3 ORCA-2 Trail Of Cytisinicline In Smoking Cessation Clears Final Review By Data Safety Monitoring Committee Benzinga

08:32AM EST Achieve Life Sciences Announces Phase 3 ORCA-2 Trial Of Cytisinicline In Smoking Cessation Clears Final Review By Data Safety Monitoring Committee (DSMC) Benzinga

08:30AM EST Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced the completion of the fifth and final Data Safety Monitoring Committee (DSMC) review for its Phase 3 ORCA-2 smoking cessation trial of cytisinicline. GlobeNewswire Inc

Nov 15, 2021

10:44AM EST ACHV: Early 2022 Start to ORCA-3 and ORCA-V1 Benzinga

Nov 9, 2021

05:36PM EST Achieve Life Sciences Q3 EPS $(0.71) Beats $(1.11) Estimate Benzinga

11:42AM EST The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data Benzinga

11:25AM EST Earnings Scheduled For November 9, 2021 Benzinga

Nov 4, 2021

08:30AM EDT Achieve Life Sciences Announces Participation in November Investor GlobeNewswire Inc

Nov 2, 2021

10:58AM EDT Achieve Life Sciences Announces FDA Acceptance Of IND Application For Cytisinicline's Second Planned Indication For Nicotine E-cigarette Cessation Benzinga

08:30AM EDT Achieve Life Sciences Announces FDA Acceptance of IND Application GlobeNewswire Inc

Oct 26, 2021

08:30AM EDT Achieve Life Sciences to Announce Third Quarter 2021 Financial GlobeNewswire Inc

Oct 4, 2021

10:21AM EDT Alliance Global Partners Initiates Coverage On Achieve Life Sciences with Buy Rating, Announces Price Target of $25 Benzinga

Sep 27, 2021

10:44AM EDT 'Achieve Life Sciences: Blockbuster Anti-Smoking Opportunity' -TipRanks Report Benzinga

Aug 19, 2021

10:57AM EDT The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck Benzinga

Aug 18, 2021

07:38AM EDT The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline Benzinga

Aug 17, 2021

08:28AM EDT The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business Benzinga

Aug 13, 2021

05:33AM EDT Achieve Life Sciences Announced Expansion of Cytisinicline Clinical Operations Team Benzinga

Aug 12, 2021

08:09AM EDT The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma Benzinga

Aug 11, 2021

04:25PM EDT Achieve Life Sciences Q2 EPS $(1.53) Misses $(1.22) Estimate Benzinga

08:14AM EDT The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering Benzinga

Aug 9, 2021

11:07AM EDT The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight Benzinga

Jul 12, 2021

10:06AM EDT UPDATE: Zack SCR Report On Achieve Life Sciences Recently Tweeted Was From June 28 Benzinga

Jun 29, 2021

08:17AM EDT The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout Benzinga

Jun 28, 2021

09:36AM EDT Achieve Life Sciences Shares Up 7.3%; Hearing Zacks Sets $58 Price Target Benzinga

Jun 23, 2021

10:04AM EDT Benzinga's Top Ratings Upgrades, Downgrades For June 23, 2021 Benzinga

09:00AM EDT Oppenheimer Initiates Coverage On Achieve Life Sciences with Outperform Rating, Announces Price Target of $23 Benzinga

May 25, 2021

02:49PM EDT Mid-Afternoon Market Update: Dycom Industries Drops Following Q1 Results; The Joint Corp Shares Slide Benzinga

12:21PM EDT Mid-Day Market Update: US Stocks Turn Lower; Provention Bio Shares Surge Benzinga

11:46AM EDT Achieve Life Sciences shares are trading lower after the company announced a proposed underwritten public offering. No size was disclosed. Benzinga

11:33AM EDT Achieve Life Sciences Stock Plunges After Raising $20M Via Equity at 19% Discount Benzinga

08:34AM EDT Achieve Life Sciences Prices 2,857,143 Share Common Stock Offering At $7/Share Benzinga

May 24, 2021

04:08PM EDT Achieve Life Sciences Announces Proposed Underwritten Public Offering; No Size Disclosed Benzinga

May 13, 2021

08:10AM EDT The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use Benzinga

04:15AM EDT Earnings Scheduled For May 13, 2021 Benzinga

Apr 14, 2021

08:12AM EDT Achieve Earlier Announced The Publication of the ORCA-1 Phase 2b Clinical Trial of Cytisinicline in Adult Smokers in Nicotine and Tobacco Research Benzinga

Mar 25, 2021

11:00AM EDT Achieve Life Sciences shares were trading higher after the company announced online publication of the results from the Phase 3 RAUORA trial in the scientific journal Addiction. Benzinga

06:11AM EDT Achieve Announces Publication Of The RAUORA Head-to-Head Non-Inferiority Clinical Trial Comparing Cytisinicline and Chantix(R) In Addiction Benzinga

Mar 11, 2021

04:12PM EST Achieve Life Sciences Q4 EPS $(1.11) Beats $(1.25) Estimate Benzinga

08:19AM EST The Daily Biotech Pulse: Contrasting COVID-19 Treatment Readouts From Roche, Vir, Delay In Kadmon's FDA Review, Alzheimer's Data From Prothena Benzinga

03:35AM EST Earnings Scheduled For March 11, 2021 Benzinga

Mar 6, 2021

10:58AM EST The Week Ahead In Biotech (March 7-13): Conference Presentations And More Earnings Benzinga

Feb 24, 2021

06:40AM EST Achieve Life Sciences Highlights Presentation Of Data on Smoker And E-Cigarette User Attitudes And Perceptions On Quitting At The Society For Research On Nicotine & Tobacco (SRNT) Annual Meeting On Feb. 24th Benzinga

Dec 7, 2020

04:06PM EST Achieve Life Sciences, Inc. Announces Closing of $17.3 Million Underwritten PR Newswire

Dec 3, 2020

08:02AM EST Achieve Life Sciences Announces Pricing of $15 Million Public Offering PR Newswire

Nov 30, 2020

07:10AM EST Achieve Life Sciences Unveils Proposed Underwritten Public Offering Of 1.5 Mln Shares Of Its Common Stock RTTNews

07:09AM EST Achieve Life Sciences Announces Proposed Public Offering of 1.5M Shares Benzinga

07:01AM EST Achieve Life Sciences Announces Proposed Public Offering PR Newswire

Nov 12, 2020

04:06PM EST Achieve Reports Financial Results for Third Quarter 2020 and Provides Corporate PR Newswire

03:10PM EST Achieve Life Sciences Q3 EPS $(1.14) Beats $(1.31) Estimate Benzinga

07:44AM EST The Daily Biotech Pulse: AstraZeneca's Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal Benzinga

04:18AM EST Earnings Scheduled For November 12, 2020 Benzinga

Nov 8, 2020

03:58PM EST The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions Benzinga

12:47PM EST The Week Ahead In Biotech: Earnings, Conference Presentations And IPOs Benzinga

Oct 29, 2020

05:30AM EDT Achieve Life Sciences to Announce Third Quarter 2020 Financial Results and Host PR Newswire

Oct 27, 2020

05:30AM EDT Achieve Life Sciences to Host Smoking Cessation Key Opinion Leader Virtual PR Newswire

Oct 7, 2020

10:34AM EDT Achieve Life Sciences Announces Start Of Phase 3 ORCA-2 Clinical Trial Evaluating Cytisinicline For Smoking Cessation Benzinga

06:34AM EDT Achieve Life Sciences Begins Start Of Phase 3 ORCA-2 Clinical Trial Evaluating Cytisinicline For Smoking Cessation RTTNews

06:30AM EDT Achieve Life Sciences Announces Start of Phase 3 ORCA-2 Clinical Trial PR Newswire

Sep 30, 2020

08:08AM EDT Achieve Life Sciences Promotes John Bencich To CEO RTTNews

08:04AM EDT Achieve Life Sciences Announces Appointment of John Bencich to Chief Executive Officer & Dr. Cindy Jacobs to President Benzinga

08:03AM EDT Achieve Life Sciences Says Promotes John Bencich To CEO RTTNews

08:01AM EDT Achieve Life Sciences Announces Appointment of John Bencich to Chief Executive PR Newswire

Sep 18, 2020

10:45AM EDT Achieve Life Sciences shares are trading higher after the company highlighted data from the evaluation of cytisinicline versus Chantix in 5-HT3 receptor binding assay study at the Society for Research on Nicotine and Tobacco European. Benzinga

10:40AM EDT Shares of Achieve Life Sciences, Inc. (ACHV) have gapped up nearly 20% Friday morning after the clinical-stage pharmaceutical company announced that its cytisinicline beat Pfizer's varenicline in smoking cessation study. RTTNews

09:32AM EDT Achieve Life Sciences: RAUORA Trial Data Shows Significantly Fewer Side Effects With Higher Quit Rates For Cytisinicline RTTNews

09:31AM EDT UPDATE: Achieve Says 'Subjects in the Cytisinicline Arm Were 55% More Likely to Quit Smoking at 6 Months Compared to Subjects Who Received Varenicline' Benzinga

09:30AM EDT Demonstrating Significantly Fewer Side Effects with Higher Quit Rates for Cytisinicline (cytisine) Compared to Chantix(r) (varenicline) in First Head-to-Head Comparative Study PR Newswire

09:30AM EDT Achieve Life Sciences Issues Press Release Highlighting Presentation Of RAUORA Trial Data Showing 'Significantly Fewer Side Effects with Higher Quit Rates for Cytisinicline (cytisine) Compared to Chantix' Benzinga

09:27AM EDT Achieve Life Sciences Shares Halted News Pending Benzinga

07:10AM EDT Achieve Life Sciences Announces Results From Evaluation Of Cytisinicline Vs Chantix In 5-HT3 Receptor Study RTTNews

07:06AM EDT Achieve Life Sciences Highlights Data From Evaluation Of Cytisinicline Vs. Chantix In 5-HT3 Receptor Binding Assay Study At Society for Research on Nicotine and Tobacco European Meeting Benzinga

07:01AM EDT (cytisine) versus Chantix(r) (varenicline) in 5-HT3 Receptor Binding Assay Study PR Newswire

Sep 17, 2020

10:36AM EDT Lake Street Initiates Coverage On Achieve Life Sciences with Buy Rating, Announces Price Target of $30 Benzinga

Sep 3, 2020

05:30AM EDT Achieve Life Sciences to Present at Upcoming Investor Conferences PR Newswire

Aug 6, 2020

05:14PM EDT Achieve Life Sciences Q2 EPS $(1.68) Beats $(2.47) Estimate Benzinga

04:06PM EDT Achieve Reports Financial Results for Second Quarter 2020 and Provides Update PR Newswire

07:57AM EDT The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO Benzinga

07:19AM EDT Biocryst Pharmaceuticals Q2 EPS $(0.24) Beats $(0.25) Estimate Benzinga

Aug 4, 2020

09:07AM EDT Achieve Life Sciences Prices ~476K Share Offering At $10.50/Share Benzinga

09:06AM EDT Achieve Life Sciences Prices Public Offering Of 476,187 Shares At $10.50/shr RTTNews

09:06AM EDT Achieve Life Sciences Prices Public Offering Of 476,187 Shares At $10.50 Per Share RTTNews

09:02AM EDT Achieve Life Sciences Announces Pricing of $6.5 Million Public Offering PR Newswire

Aug 3, 2020

04:01PM EDT Archive Life Sciences Announces A Common Stock Offering; No Size Disclosed Benzinga

04:00PM EDT Achieve Life Sciences Announces Proposed Public Offering PR Newswire

Jul 31, 2020

08:32AM EDT Achieve Announces Patent Granted In U.S. For Novel Analogs Of Cytisinicline For Use In CNS And Addiction Indications Benzinga

08:30AM EDT Achieve Announces Patent Granted in the U.S. for Novel Analogs of Cytisinicline PR Newswire

Jul 28, 2020

05:30AM EDT Achieve Life Sciences to Announce Second Quarter 2020 Financial Results and PR Newswire